Novel cocrystals of brexpiprazole with improved solubility
Authors:
- Veeraswamy RamaVRVeeraswamy Rama
- Siddaiah VidavulurSVSiddaiah Vidavulur
- Pratap V. TadikondaPTPratap V. Tadikonda
- Nagaraju RajanaNRNagaraju Rajana
- Sudhir MittapalliSMSudhir Mittapalli
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Journal of Crystal Growth
- Vol. 551
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical role of brexpiprazole in depression and schizophreniaTherapeutics and Clinical Risk Management, 2017
- Pharmaceutical cocrystals: walking the talkChemical Communications, 2016
- Brexpiprazole: First Global ApprovalDrugs, 2015
- Crystal Engineering: From Molecule to CrystalJournal of the American Chemical Society, 2013
- Improving Solubility and Pharmacokinetics of Meloxicam via Multiple-Component Crystal FormationMolecular Pharmaceutics, 2012
- Polymorphs, Salts, and Cocrystals: What’s in a Name?Crystal Growth & Design, 2012
- Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of LamotrigineCrystal Growth & Design, 2009
- Pharmaceutical Cocrystals and Their Physicochemical PropertiesCrystal Growth & Design, 2009
- Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discovery Today, 2007
- Crystal Engineering: A Holistic ViewAngewandte Chemie International Edition, 2007